News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
749,004 Results
Type
Article (53307)
Company Profile (296)
Press Release (695401)
Multimedia
Podcasts (73)
Webinars (13)
Section
Business (215097)
Career Advice (2859)
Deals (36992)
Drug Delivery (119)
Drug Development (85867)
Employer Resources (184)
FDA (17028)
Job Trends (15811)
News (365248)
Policy (35367)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2909)
Academic (1)
Accelerated approval (5)
Adcomms (27)
Allergies (90)
Alliances (52676)
ALS (97)
Alzheimer's disease (1469)
Antibody-drug conjugate (ADC) (141)
Approvals (17001)
Artificial intelligence (273)
Autoimmune disease (24)
Automation (16)
Bankruptcy (387)
Best Places to Work (12182)
BIOSECURE Act (20)
Biosimilars (115)
Biotechnology (214)
Bladder cancer (71)
Brain cancer (30)
Breast cancer (288)
Cancer (2277)
Cardiovascular disease (192)
Career advice (2397)
Career pathing (33)
CAR-T (157)
Cell therapy (436)
Cervical cancer (20)
Clinical research (69528)
Collaboration (863)
Compensation (528)
Complete response letters (26)
COVID-19 (2786)
CRISPR (44)
C-suite (252)
Cystic fibrosis (103)
Data (2137)
Decentralized trials (2)
Denatured (22)
Depression (51)
Diabetes (279)
Diagnostics (6715)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (128)
Drug pricing (117)
Drug shortages (28)
Duchenne muscular dystrophy (99)
Earnings (88204)
Editorial (42)
Employer branding (23)
Employer resources (157)
Events (118537)
Executive appointments (745)
FDA (18280)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (774)
Gene editing (113)
Generative AI (25)
Gene therapy (321)
GLP-1 (800)
Government (4865)
Grass and pollen (6)
Guidances (52)
Healthcare (20057)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (134)
Indications (29)
Infectious disease (2940)
Inflammatory bowel disease (145)
Inflation Reduction Act (9)
Influenza (54)
Intellectual property (95)
Interviews (555)
IPO (16938)
IRA (47)
Job creations (4062)
Job search strategy (1978)
Kidney cancer (11)
Labor market (38)
Layoffs (516)
Leadership (21)
Legal (8710)
Liver cancer (79)
Lung cancer (330)
Lymphoma (148)
Machine learning (6)
Management (62)
Manufacturing (315)
MASH (72)
Medical device (14026)
Medtech (14031)
Mergers & acquisitions (20576)
Metabolic disorders (731)
Multiple sclerosis (83)
NASH (23)
Neurodegenerative disease (103)
Neuropsychiatric disorders (32)
Neuroscience (2038)
NextGen: Class of 2025 (7121)
Non-profit (4885)
Northern California (2642)
Now hiring (39)
Obesity (393)
Opinion (253)
Ovarian cancer (75)
Pain (90)
Pancreatic cancer (84)
Parkinson's disease (156)
Partnered (21)
Patents (238)
Patient recruitment (108)
Peanut (51)
People (61894)
Pharmaceutical (70)
Pharmacy benefit managers (19)
Phase I (21612)
Phase II (30505)
Phase III (22807)
Pipeline (1173)
Policy (155)
Postmarket research (2911)
Preclinical (9238)
Press Release (70)
Prostate cancer (102)
Psychedelics (38)
Radiopharmaceuticals (255)
Rare diseases (406)
Real estate (6388)
Recruiting (72)
Regulatory (23991)
Reports (47)
Research institute (2559)
Resumes & cover letters (452)
Rett syndrome (4)
RNA editing (4)
RSV (46)
Schizophrenia (76)
Series A (135)
Series B (87)
Service/supplier (13)
Sickle cell disease (58)
Southern California (2270)
Special edition (16)
Spinal muscular atrophy (159)
Sponsored (32)
Startups (3860)
State (2)
Stomach cancer (16)
Supply chain (72)
Tariffs (37)
The Weekly (49)
United States (23151)
Vaccines (758)
Venture capitalists (42)
Weight loss (271)
Women's health (36)
Worklife (18)
Date
Today (81)
Last 7 days (673)
Last 30 days (2538)
Last 365 days (34067)
2025 (10298)
2024 (36652)
2023 (41587)
2022 (52797)
2021 (57466)
2020 (56333)
2019 (49551)
2018 (37499)
2017 (34361)
2016 (34236)
2015 (40296)
2014 (34215)
2013 (29597)
2012 (31653)
2011 (32196)
2010 (30409)
Location
Africa (914)
Alabama (53)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (42269)
Australia (7703)
California (6055)
Canada (1997)
China (526)
Colorado (266)
Connecticut (277)
Delaware (145)
Europe (93684)
Florida (891)
Georgia (207)
Idaho (61)
Illinois (556)
India (27)
Indiana (315)
Iowa (11)
Japan (161)
Kansas (105)
Kentucky (25)
Louisiana (10)
Maine (62)
Maryland (912)
Massachusetts (4569)
Michigan (222)
Minnesota (401)
Mississippi (2)
Missouri (89)
Montana (29)
Nebraska (25)
Nevada (60)
New Hampshire (66)
New Jersey (1712)
New Mexico (30)
New York (1725)
North Carolina (1033)
North Dakota (8)
Northern California (2642)
Ohio (203)
Oklahoma (14)
Oregon (37)
Pennsylvania (1358)
Puerto Rico (12)
Rhode Island (34)
South America (1291)
South Carolina (22)
South Dakota (1)
Southern California (2270)
Tennessee (104)
Texas (895)
Utah (182)
Virginia (146)
Washington D.C. (66)
Washington State (565)
West Virginia (3)
Wisconsin (54)
749,004 Results for "fabric genomics formerly known as omicia inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale
April 17, 2025
·
7 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Business
Fabric Genomics Partners with Intermountain Children’s Health to Enhance Precision Diagnosis of Infants and Children Using Whole Genome Sequencing from Broad Clinical Labs
Fabric Genomics is announcing a new partnership with Intermountain Children’s Health to analyze the whole genomes of children sequenced by the Broad Clinical Labs to help speed diagnosis of kids who may have genetic diseases.
March 13, 2024
·
5 min read
Press Releases
Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer
January 21, 2025
·
9 min read
Oxford Nanopore Technologies and Fabric Genomics Collaborate to Launch an Integrated Whole-Genome Sequencing Solution to Advance the Future of Paediatric Patient Care
Oxford Nanopore Technologies plc and Fabric Genomics announced a new collaboration to develop a scalable software solution for the end-to-end analysis and clinical reporting of rich genomic data.
October 31, 2023
·
5 min read
Deals
Fabric Acquires MeMD, Expanding Virtual Care Services to 30,000 Employers and 5 Million Members
Fabric, a leading healthcare technology company and care enablement system, announced the acquisition of MeMD from Walmart Inc. MeMD is a leading provider of virtual behavioral, urgent, and primary care benefits for 30,000 corporate, institutional, and health plan partners and 5 million members.
June 28, 2024
·
3 min read
Press Releases
Moss Genomics Inc. Announces Leadership Changes
February 26, 2025
·
5 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Business
Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company’s Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026
Align Technology, Inc. today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately.
May 22, 2024
·
5 min read
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
1 of 74,901
Next
